Search - tctmd.com

Displaying 621 - 640 of 645

Sort: Relevancy | Date

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Yael L. Maxwell

June 05, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

Statins Reduce Amputations After Lower Extremity Procedures

Jason Kahn

December 30, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Conference News EuroPCR 2012

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Jason Kahn

May 17, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Conference News

ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin

August 29, 2011

Advertisement

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Poor Responders to Statins at Risk for CAD Progression

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Statins More Beneficial Before PCI Than After in ACS Patients

Statins Reduce Amputations After Lower Extremity Procedures

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Statins Reduce Late Restenosis After SES Implantation

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content